Two different zinc oxide nanoparticles, as well as zinc ion, are used to study the cellular responses of the RAW264 macrophage cell line. A proteomic screen is used to provide a wide view of the molecular effects of zinc, and the most prominent results are crossvalidated by targeted studies. Furthermore, the alteration of important macrophage functions (e.g. phagocytosis) by zinc is also investigated. The intracellular dissolution/uptake of zinc is also studied to further characterize zinc toxicity. Zinc oxide nanoparticles dissolve readily in the cells, leading to high intracellular zinc concentrations, mostly as protein-bound zinc. The proteomic screen reveals a rather weak response in the oxidative stress response pathway, but a strong response both in the central metabolism and in the proteasomal protein degradation pathway. Targeted experiments confirm that carbohydrate catabolism and proteasome are critical determinants of sensitivity to zinc, which also induces DNA damage. Conversely, glutathione levels and phagocytosis appear unaffected at moderately toxic zinc concentrations.
INTRODUCTION
Zinc oxide nanoparticles are among the most widely used nanoparticles. Apart from their possible role in nanomedicine (e.g. in 1 ), they are also widely used in sunscreens 2 or as antibacterials 3 . However, zinc oxide nanoparticles are known to be toxic in man, as they are for example one of the causal agents of the metal fume fever 4 . There are also several reports on zinc oxide toxicity on different cellular models [5] [6] [7] [8] [9] [10] [11] . Although some reports show a clear role for the nanoparticles themselves 7, 12 , several reports demonstrate a clear role of dissolved zinc ion in the toxicity of zinc oxide nanoparticles [13] [14] [15] [16] . As to the role of dissolved zinc ion, some reports suggest a major role for extracellular dissolution 11, 15, 17 , while other reports suggest that intracellular dissolution in lysosomes after uptake of nanoparticles is predominant 7, 12, 13, 18 .
As to the toxicity mechanisms of zinc oxide nanoparticles, most of the studies imply the oxidative stress pathway 5, 9, 19 , leading to DNA damage 5, 8 , although interference with ion homeostasis has also been implicated 9, 20 . However, these are mostly targeted studies investigating classical mechanisms in nanoparticles toxicity, and studies using wider and less oriented approaches are still rare 21 .
Due to their known implication in diseases related to particulate matter such as asbestosis 22, 23 , and the well-known inflammatory dimension of the zinc oxideinduced metal fume fever 24, 25 , myeloid cells and especially macrophages are a typical target cell type when investigating the toxicity of zinc oxide nanoparticles.
Thus, myeloid cells have been used in several studies dealing with zinc oxide toxicity 6, 11, 21, 26, 27 . Most of these studies have concentrated on the classical chronic inflammation scheme, and investigated the production of pro-inflammatory cytokines upon treatment with zinc oxide. The results are however conflicting, some studies describing the production of some cytokines 26, 27 while others do not describe any cytokine production 6 .
However, a wide scope approach aiming at finding the key responses of macrophages to zinc oxide nanoparticles is still missing, despite the recent transcriptomic work recently described 21 . This is why we undertook a combined targeted and proteomic study of the responses of the mouse macrophage cell line RAW264 to zinc ion and to two different types of zinc oxide nanoparticles (coated and uncoated). RAW264 cells are one of the classical macrophage models and have been often used for studying the effects of nanoparticles in macrophages (e.g. in 26, [28] [29] [30] [31] [32] [33] . They are also one of the few cell lines able to produce NO upon LPS stimulation 34 , a feature absent from the other classical human macrophage model THP-1. The rationale of this comparison was to check if the coating can modify not only the toxicity of the nanoparticle 19 , but can also alter the cellular responses to the nanoparticles.
RESULTS

Nanoparticles characterization
The two commercial nanoparticles were characterized by several methods, and the results are summarized in Table 1 and in supplementary figures 1 to 3. The zinc oxide nanoparticles were rod shaped, while the cationic coated zinc oxide was more spherical.
The XRD diagrams conformed to those of nominal zinc oxide, showing no crystalline impurities. The zeta potential was positive for both nanoparticles, with the cationic coating accounting for an increase in the positive surface charge. Finally, the nanoparticles could be dispersed in complete culture medium as aggregates of ca. 200 nM in diameter.
In order to verify that the nanoparticles were not degraded prior to their contact with the cells, we checked their dissolution in the 50mg/ml intermediate nanoparticules dispersion (corresponding to 625mM zinc). Only 1mM dissolved zinc was measured after 7 days.
Determination of the effective doses
For carrying out a proteomic study, we had to determine the dose for which we would obtain the best compromise between viability and biological effect. We therefore decided to use a LD20, i.e. a dose leading to a cell mortality of 20%, knowing that the mortality of a control culture is around 5%.
The LD20 was obtained at 8 µg/ml for the ZnO nanoparticles, 7µg/ml for the coated cationic ZnO nanoparticles, and at 120µM for zinc ion (supplementary figure 4). These concentrations were used for the subsequent studies.
Determination of nanoparticles fate in cells
Transmission electron microscopy was performed to determine the fate of the nanoparticles when in presence of macrophages. These experiments (Figure 1) showed that nanoparticles were present in vacuolar structures identified as multivesicular bodies and as lysosomes. These results were in line with what can be expected from professional phagocytes. Moreover, these results demonstrate that macrophages seem to ingest both nominal nanoparticles and nanoparticles aggregates present in the culture medium and to break them down in the endosomes-lysosomes. Indeed, eroded nanoparticles can easily be seen ( Figure 1B and 1C), demonstrating this intracellular erosion phenomenon.
In order to gain further insights into the intracellular zinc concentration, we measured the zinc concentration that could be released from a post nuclear supernatant prepared from cells exposed to zinc ion or ZnO nanoparticles. The results, shown in The proteomic analysis of whole cell extracts is detailed in Figure 2 and [36] [37] [38] [39] . The protein changes were detected through the use of a variance-based screen 40 . Compared to a fold-change screen, this process compensates automatically for the variance of each spot. This excludes automatically spots with a high coefficient of variation, but enables to take into account small but reproducible changes when the coefficient of variation is low, thus avoiding the arbitrary exclusion of changes that can be biologically meaningful 40 .
As an example, the endoplamic reticulum protein ERP29 is selected as significantly modulated, although the fold change is only 0.8 fold. This is due to the fact that the coefficient of variation of this spot is only 8% in the control group and 4% in the zinc ion-treated group.
Metabolic enzymes, cytoskeletal proteins and proteins implicated in the proteasomal degradation are strongly represented in the list of modulated proteins. Moreover, more than a third of these modulated proteins (17/45) The proteomic analysis of zinc binding proteins is detailed in Figure 3 and Table 4 . First, it should be noted that the background given by an "empty" resin (i.e. without a bound metal) was extremely low, as a basically empty 2D gel was obtained (data not shown).
However, to minimize any possible bias, the experiments were carried out on three different biological replicates and only the proteins significantly enriched in the zinc column compared to the starting extract (p≤ 0.05) were further analyzed and listed in , to confirm the biological relevance of the proteomically detected protein modulations.
Characterization of the oxidative stress response
Oxidative stress is now used as a toxicological marker for almost all toxicants, and zinc ion and zinc oxide are no exception to this rule 5, 14 . However, we did not detect any change in the classical oxidative stress response proteins, as opposed to what was observed with copper oxide nanoparticles 42 . Nonetheless, we detected an increase in two non classical proteins that can be involved in the antioxidant response, namely flavin reductase (spot O3) and glutamate cysteine ligase (GCLM, spot O2). The latter protein is of interest, as it controls the limiting step in glutathione biosynthesis. Furthermore, glutathione depletion has been suggested as an important mechanism in zinc toxicity 43 .
We therefore measured the intracellular levels of reduced glutathione by a monochlorobimane conjugation approach 44 . The results, shown on Figure 4A , demonstrate a moderate but reproducible increase in GSH levels, validating the increase of GCLM detected via proteomics (fold change 1.6 to 1.8 in Table 3 ). This suggests that macrophages are able to counteract the GSH chelation due to zinc ion by de novo synthesis of glutathione, a situation quite different from the one observed in neurons 43 .
Another interesting protein detected via our proteomic screen and involved in the oxidative stress response is the flavin/biliverdin reductase (spot O3), which reduces biliverdin into bilirubin. This bilirubin/biliverdin cycle has been implied in hydrogen peroxide destruction 45 .
As this protein has a detectable enzymatic activity, we decided to confirm the proteomic result by a direct assay of the biliverdin reductase activity (Table 5) . A significant induction was observed, as detected by the proteomic screen.
Characterization of the phagocytic response
As we observed several changes in proteins involved in the actin (e.g. ARP proteins spots C5 and C9, lsp1 protein spot C3, glia maturation factor spot C1, twinfilin spot C4 or gelsolin spots C7) and tubulin cytoskeleton (MAPRE1spot C2 and TCP1 spot C6), we could anticipate perturbations in the phagocytic capacity of zinc-treated macrophages.
We thus assessed this important function of macrophages upon treatment with zinc ion or ZnO nanoparticles. The results, presented on Figure 4B , show that macrophages are still highly phagocytic even when treated with zinc, as long as the concentrations remain non toxic.
DNA damage
As several nanoparticles have been shown to induce DNA damage 8, [46] [47] [48] , we decided to test whether zinc-based nanoparticles can induce DNA damage, using an alkaline comet assay. The results, shown on Figure 5 , demonstrate that zinc ion, zinc oxide but not cationized zinc oxide, are able to induce DNA damage even at the moderately toxic LD20 dose. This also confirms previous results , e.g. on normal nasal mucosa cells 8 .
Metabolic perturbations
Our proteomic screens highlighted several proteins implicated in energy metabolism, and more specifically in the glycolysis and pentose phosphate pathways (spots E1 to E5). These proteins were found in both screens, i.e. proteins responding to the zinc stress and zinc-binding proteins. In fact, several important energy metabolism enzymes have been shown to bind zinc and be inhibited by it [49] [50] [51] .
We proceeded to a two step validation. First, the enolase and 6-phosphogluconate dehydrogenase activities were measured (Table 5 ). Here again, the enzymatic activities confirmed the proteomic results, showing an increase upon treatment of the cells with zinc. As the 6-phosphogluconate dehydrogenase was also found in the zinc binding proteins, we hypothesized that it could be inhibited by zinc in the context of a complete cell extract, and not only as a purified protein 52 . We therefore assayed the 6-phosphogluconate dehydrogenase activity in the presence of added zinc acetate, and found an IC50 close to 12µM. As this concentration is much lower than the one detected in our cell extracts upon zinc treatment, it can be reasonably hypothesized that the pentose phosphate pathway is impaired during zinc overload. This could contribute to the observed oxidative stress, as the pentose phosphate pathway is a major source of NADPH, required by many reductases implied in the defense against oxidative stress (e.g. glutathione reductase, biliverdin reductase and thioredoxin reductase). In contrast, GAPDH was marginally inhibited by zinc, with only 30% inhibition at 100µM zinc (data not shown).
Finally, we tested the final metabolite of the pentose phosphate and glycolysis pathways, i.e. pyruvate. First, zinc stress induced a higher level of pyruvate in cells, as shown in Figure 6A . This is in line with the activation of the glycolytic metabolism observed in occupational medicine 53 , and suggested that pyruvate is a critical metabolite for survival in presence of a zinc stress, as in neuronal cells 54, 55 . Our results demonstrate that pyruvate acts as a survival factor upon zinc stress, both for zinc ion ( Figure 6B ), zinc oxide ( Figure 6C ) and cationized zinc oxide ( Figure 6D ). Thus, energy metabolism is one of the crucial determinants in resistance to zinc.
Our proteomic screens also highlighted several proteins of the proteasomal degradation pathway such as proteasome subunits (spots D4 and D6) and proteins implicated in the ubiquitination step (spots D5 and D1 to D3). In order to investigate the putative implication of this pathway in the response to zinc, we assessed the survival to zinc treatment after proteasome inhibition with the inhibitor MG132. The results, shown on Figure 7 , demonstrate that proteasome inhibition increases zinc toxicity, which can be attributed to a synergistic effect between the inhibition of the proteasome by MG132 and the known inhibition of the proteasome by zinc 56 .
DISCUSSION
When taken together, the results of both the proteomic and targeted experiments produce a landscape of the cellular response to zinc. Opposite to what has been observed with copper 42 , zinc ion and zinc oxide do not induce by themselves a strong oxidative stress. This is consistent with the fact that zinc, unlike copper, iron or manganese, cannot undergo redox cycles between ions of different valency.
Thus, the almost generic oxidative stress that has been observed with zinc oxide 5, 14 , can be attributed to a more general perturbation leading to an imbalance in cellular redox cycles and thus to ROS production.
From our results, a key determinant in zinc toxicity appears to be a general metabolic perturbation. Many carbohydrate catabolic enzymes are either induced upon zinc treatment (Table 1) or bind to zinc (Table 2) , and the overall result is both an increase in pyruvate production and the evidence that pyruvate is a critical metabolite for cell survival during zinc treatment. This is in line with previous studies on neuronal cells 51 , and suggests that an important determinant in zinc toxicity is a metabolic impairment leading to an "energy shortage" in zinc-treated cells, leading eventually to cell death. To measure nanoparticles dissolution in the 50 mg/ml intermediate dispersion used
prior to addition in the cell cultures, the dispersion was centrifuged at 270,000g for 45 minutes to sediment the nanoparticles 58 .
The dissolved zinc concentration in the supernatant was then determined, after the appropriate dilution in water, by a xylenol orange colorimetric assay 59 , using 0.1M MES buffer pH 6 and 60µM xylenol orange as an indicator. Zinc concentration was then determined using an adapted xylenol orange colorimetric assay 59 . Briefly, 1 ml of medium/cell extract was first cooled in an ice bath for 30 minutes. TCA was added to a 5% w/v final concentration, and the mixture was left for 1 hour on ice to denature the proteins and release complexed zinc ion.
Nanoparticles dissolution in cells
The mixture was centrifuged for 10 minutes at 15,000g, the supernatant recovered and its volume measured. A neutralizing solution (2 M MES-Na salt) was added (0.25 volume/volume of supernatant) was added, followed by 0.03 volume of a 2 mM xylenol orange solution in water. The color was left to develop for 5 minutes and the absorbance measured at 565 nm. Under these conditions, no interference was observed with magnesium, calcium or iron. As the extract is diluted 5fold compared to the initial cell volume, the concentration read in the assay is multiplied by 5 to obtain the intracellular zinc concentration.
Cell culture
The mouse macrophage cell line RAW 264.7 was obtained from the European Cell Culture Collection (Salisbury, UK). The cells were cultured in RPMI 1640 medium + 10% fetal bovine serum. Cells were seeded at 200,000 cells/ml and harvested at 1,000,000 cells per ml. For treatment with zinc ion or zinc oxide nanoparticles, cells were seeded at 500,000 cells/ml. They were treated with zinc on the following day and harvested after a further 24 hours in culture. Cell viability was measured by the neutral red uptake assay 60 . All experiments were carried out at least in triplicate on independent cultures.
Phagocytosis activity measurement
The phagocytic activity was measured after treatment with zinc using fluorescent latex beads (1µm diameter, green labelled, catalog number L4655 from Sigma) and flow cytometry, essentially as described in 6142 .
Transmission Electron Microscopy
Transmisson electron microscopy was carried out as previously described 42 on cells fixed with glutaraldehyde, included in Epon and post stained with lead citrate and uranyl acetate. Energy dispersive X-ray (EDX) analysis was performed on sample sections. Spectra were obtained using a large angle SDD-EDS attached to a Jeol 2010 TEM.
Intracellular glutathione measurements
Intracellular glutathione levels were analyzed by the monochlorobimane technique 44 , with some modifications 6242 .
Pyruvate assay
The pyruvate content of cells was determined using the pyruvate assay kit from Sigma (ref # MAK071), used according to the manufacturer instructions.
Enzyme assays
The enzymes were assayed according to published procedures. Enolase was assayed by the direct conversion of 2-phosphoglycerate into phosphoenolpyruvate, detected at 240nm 63 .6-phosphogluconate dehydrogenase was assayed by a coupled assay using Nitro blue tetrazolium as the final acceptor and phenazine methosulfate as a relay 64 . Biliverdin reductase was assayed directly for the NADPHdependent conversion of biliverdin into bilirubin, followed at 450nm 45 .
The cell extracts for enzyme assays were prepared by lysing the cells for 20 minutes at 0°C in Hepes 20 mM pH 7.5, MgCl2 2 mM, KCl 50 mM, EGTA 1 mM, SB 3-14 0.15% w/v, followed by centrifugation at 15,000g for 15 minutes to clear the extract.
The protein concentration was determined by a dye-binding assay 65 .
For the zinc inhibition studies, the cell extracts were first diluted in the assay buffer (final protein concentration 0.2 mg/ml), supplemented with defined concentrations of zinc acetate. The resulting solutions were incubated at 37°C for 30 minutes to allow zinc binding. The substrates and cofactors were then added and the activity measured spectrophotometrically.
Comet assay
The comet assay was performed essentially as described in Jugan et al. 46 . Briefly, microscope slides were coated with 1% normal melting point agarose (NMA) and allowed to dry. Around 10,000 cells (75 µL of each cell suspension) were mixed with 0.6 % low melting point agarose (LMPA) and deposited over the agarose layer, and the LMPA/cells mix was allowed to solidify on ice. The slides were immersed overnight in cold lysis solution (2.5 M NaCl, 100 mM EDTA, 10 mM Tris, 1% SDS, 10% DMSO, 1 % Triton X-100) at 4°C. DNA was then allowed to unwind for 30 min in alkaline electrophoresis solution (300 mM NaOH, 1 mM EDTA, pH > 13).
Electrophoresis was performed in a field of 0.7 V/cm and 300 mA current for 30 min. nm emission filter at ×20 magnification. Comet length and intensity were measured by using Comet IV software (Perceptive Instruments, Suffolk, UK).
Proteomics
Sample preparation, 2D gel analysis and mass spectrometry were performed essentially as previously described 42 and the detailed procedures can be found in the supplementary material and methods. Thus, only the specific methods will be described in detail in this section
Sample preparation: zinc-binding proteins Zinc-binding proteins were prepared by an affinity enrichment, using zinc ion loaded onto iminodiacetic agarose (Sigma#I4510). One milliliter of gel suspension was diluted with one milliliter of gel suspension buffer (Hepes 20 mM pH 7.5, KCl 50 mM), incubated for 10 minutes in a cold room on a rotating wheel, and centrifuged at 10,000g for 10 minutes. The gel pellet was then resuspended in 1.5 ml of gel suspension buffer, and the agitation-centrifugation cycle was repeated. The gel pellet was then resuspended in 1.5 ml of gel suspension buffer, to which zinc acetate was added at a final concentration of 0.1 M. The suspension was agitated on the rotating wheel (cold room) for 30 minutes, then centrifuged as described above. Five rinsing cycles (suspension in 1.5 ml of gel suspension buffer, rotating wheel for 15 minutes, centrifugation) were then applied. The gel was ready for use after the last centrifugation.
The native cell extract was prepared as follows: Cells were collected by scraping, , and transferred on top of the SDS gels.
Ten percent gels (160x200x1.5 mm) were used for the second dimension. The Tris taurine buffer system 71 was used and operated at a ionic strength of 0.1 and a pH of 7.9. Detection was carried out by fast silver staining 72 .
Image analysis
The gel images were analyzed using the Delta 2D software (v 3.6). Three gels coming from three independent cultures were used for each experimental group. Spots that were never expressed above 100 ppm of the total spots were first filtered out. Then, significantly-varying spots were selected on the basis of their Student T-test p-value between the treated and the control groups. Spots showing a p-value lower than 0.05 were selected.
Mass spectrometry
The spots selected for identification were analyzed by NanoLC-MS/MS analysis, performed using a nanoLC-QTOF-MS system and a nanoLC-IT-MS system operated as described previously 42 (details can also be found in the supplementary material).
The MS/MS data were interpreted using MASCOT 2. The arrows point to spots that show reproducible and statistically significant changes between the control and zinc-treated cells. Spot numbering according to Table 3 . A: analysis of the total post nuclear supernatant B: eluate from the Zn-iminodiacetic sepharose column
The arrows point to spots that show a reproducible and statistically significant increase in the column eluate compared to the starting extract. Spot numbering according to Table 4 . 
